Asset Management Corp Intra Cellular Therapies, Inc. Call Options Transaction History
Asset Management Corp
- $146 Million
- Q1 2023
Call Options
1 transactions
Others Institutions Holding ITCI
# of Institutions
399Shares Held
87.2MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$698 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$459 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$270 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$249 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$218 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.86B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...